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ABSTRACT
Different tissues contain diverse and dynamic cellular niches,
providing distinct signals to tissue-resident or migratory infiltrating
immune cells. Hedgehog (Hh) proteins are secreted inter-cellular
signalling molecules, which are essential during development and are
important in cancer, post-natal tissue homeostasis and repair. Hh
signallingmediated by the Hh-responsive transcription factor Gli2 also
has multiple roles in T-lymphocyte development and differentiation.
Here, we investigate the function of Gli2 in T-cell signalling and
activation. Gene transcription driven by the Gli2 transcriptional
activator isoform (Gli2A) attenuated T-cell activation and proliferation
following T-cell receptor (TCR) stimulation. Expression of Gli2A in
T-cells altered gene expression profiles, impaired the TCR-induced
Ca2+ flux and nuclear expression of NFAT2, suppressed upregulation
of molecules essential for activation, and attenuated signalling
pathways upstream of the AP-1 and NFκB complexes, leading to
reduced activation of these important transcription factors. Inhibition of
physiological Hh-dependent transcription increased NFκB activity
upon TCR ligation. These data are important for understanding the
molecular mechanisms of immunomodulation, particularly in tissues
where Hh proteins or other Gli-activating ligands such as TGFβ are
upregulated, including during inflammation, tissue damage and repair,
and in tumour microenvironments.
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INTRODUCTION
Peripheral T-cell activation, differentiation and clonal expansion
are controlled by complex signals, which are initiated by interaction
of the T-cell receptor (TCR) with its major histocompatibility
complex (MHC)–peptide ligand. For full activation, T-cells require
co-stimulation by binding of CD28 to CD80 and CD86 on antigen-
presenting cells (APCs). TCR and CD28 ligation lead to a series of
TCR-proximal phosphorylation events, the release of intracellular
Ca2+ stores and triggering of signalling cascades, which activate
key transcription factors including the activator protein 1 (AP-1)
complex, members of the nuclear factor of activated T-cells (NFAT)
family and nuclear factor κB (NFκB) (Huse, 2009). The
transcriptional response to TCR signalling controls the subsequent
activation and resolution of the adaptive immune response
(Thompson et al., 1989; Smith-Garvin et al., 2009; Cheng et al.,
2011). Interleukin-2 (IL-2) is a potent growth factor for T-cells in vitro
and in vivo (Smith, 1988; Boyman and Sprent, 2012). Activation of
T-cells induces synthesis of IL-2 and upregulation of cell surface
CD25 (IL-2Rα), the high-affinity IL-2 receptor subunit, thus
providing a feedback loop that enhances IL-2 signalling. Persistent
stimulation of T-cells through TCR and IL-2 signalling eventually
induces apoptotic pathways, resulting in activation-induced cell
death (AICD). The function of TCR, CD28 and cytokine signalling
in T-cell activation is well characterised, although the role of other
microenvironmental cues in altering local T-cell responses is not well
understood. Different secondary lymphoid organs, distinct tissue
niches and solid neoplasms each present diverse and dynamic cellular
microenvironments, which might provide different signals to
local resident or infiltrating T-cells. The influence of non-immune
tissue-derived molecules on T-cell activation therefore requires
investigation.
Hedgehog (Hh) proteins are secreted inter-cellular signalling
molecules that are essential for patterning during fetal development
and homeostasis of adult tissues (Neumann, 2005; Ingham and
Placzek, 2006;Agathocleous et al., 2007; Crompton et al., 2007; Jiang
andHui, 2008;Le et al., 2008).Hhpathwaymolecules are expressed in
the thymus (Outram et al., 2000; Sacedón et al., 2003), where Hh
signalling regulates multiple stages of T-cell development (Outram
et al., 2000; Shah et al., 2004; Hager-Theodorides et al., 2005; El
Andaloussi et al., 2006; Rowbotham et al., 2007; Rowbotham et al.,
2008; Hager-Theodorides et al., 2009; Rowbotham et al., 2009;
Drakopoulou et al., 2010; Furmanski et al., 2012;Michel et al., 2013).
Gene expression studies have shown that mature splenic T-cells
express the Hh signal transductionmoleculesPtch1 and Smo (Lowrey
et al., 2002; Furmanski et al., 2013). Desert Hh (Dhh) is expressed in
spleen (Perry et al., 2009; Lau et al., 2012), and Sonic Hh (Shh) is
produced by follicular dendritic cells in spleen and lymph nodes
(Sacedón et al., 2005), and by the stroma of several tissues (Sato et al.,
1999; Pola et al., 2003; Nielsen et al., 2004; Furmanski et al., 2013).
Many tumours secrete Hh ligands, and the pathway is active in wound
repair and fibrotic diseases (Jiang and Hui, 2008; Le et al., 2008).
Canonical mammalian Hh signalling is initiated by the binding
of Shh, Dhh or Ihh to the cell surface receptor Patched1
(Ptch1) (Marigo et al., 1996). This interaction relieves inhibition of
Smoothened (Smo), theHh signalling transductionmolecule (Alcedo
et al., 1996), which activates members of the Gli family of
transcription factors (Varjosalo and Taipale, 2007). Gli proteins
bind to DNA at consensus Gli-family-binding sites and directly
modulate target gene transcription.Gli2 is necessary to initiate the Hh
signal and acts mainly as a transcriptional activator in vivo, but can be
processed into truncated isoforms of the full-length Gli2 protein,
which activate (Gli2A) or repress (Gli2R) transcription (Aza-BlancReceived 7 November 2014; Accepted 30 March 2015
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et al., 2000; Bai et al., 2002). Hh ligand binding blocks production of
Gli2R, and full-lengthGli2 proteins are converted intoGli2A, altering
the cellular ratio of Gli2R:Gli2A, which regulates the cellular
response to Hh signals. In the absence of ligand, a significant
proportionof transcriptionally inactiveGli2 remains in the cytoplasm.
Gli1 can function only as a transcriptional activator and is itself a
transcriptional target of Gli2A. All Gli proteins contain a nuclear
localisation signal (NLS) and nuclear export signal (NES), which
control movement between the nucleus and cytoplasm. Upon Hh
ligand binding, Gli2A accumulates in the nucleus to activate Hh-
dependent transcription (Kim et al., 2009; Hatayama and Aruga,
2012). Interestingly, Gli2 has also been shown to be responsive to
TGFβ signal transduction in several cell types (Dennler et al., 2007),
and Gli2A function can also be regulated by Akt–PI3K and EGF
signalling (Kasper et al., 2006; Riobó et al., 2006).
Here, we show that Gli transcription factors are present in the
nucleus and cytoplasm of wild-type (WT) splenic CD4+ cells. To
investigate how Gli2-mediated transcription influences TCR
signalling in CD4+ T-cells, we used transgenic models where
transcription of target genes by Gli2 is either constitutively active
(Gli2A) or repressed (Gli2R) (Rowbotham et al., 2007; Rowbotham
et al., 2008). The Gli2A and Gli2R transgenes are driven by the Lck
promoter and so are expressed in T-lineage cells only (Buckland
et al., 2000; Shimizu et al., 2001). The transgenes are otherwise
identical in sequence and share the zinc finger domains that bind to
DNA at consensus Gli-binding sites.
We show that the ability of T-cells to signal, activate, proliferate
and respond to IL-2 is impaired in the presence of Gli2A. Our data
indicate that Gli2-dependent transcription attenuates T-cell activation
by altering the expression of genes important for several key
signalling events downstream of TCR ligation. This has
implications for our understanding of immune regulation in tissues
that express ligands able to activate Gli-dependent transcription.
RESULTS
Gli transcription factors are expressed in WT T-cells
To show that WT T-cells express the essential Hh-responsive
transcription factor Gli2, we investigated Gli2 protein expression
and localisation by western blotting extracts from CD4+ cells
purified from spleen (Fig. 1A). Gli2 was expressed in the cytoplasm
and nucleus of ex vivo unstimulated WT CD4+ lymphocytes.
Nuclear accumulation of Gli2A is associated with active Hh
signalling (Kim et al., 2009), thereforewe investigated expression of
Gli1, a canonical Gli2 target and transcriptional activator. Gli1
protein was also present in WT CD4+ T-cells. The presence of Gli1
protein and nuclear localisation of Gli2 suggest that there is Gli
transcriptional activity in WT CD4+ T-cells. These data support the
observation that differentiated CD8+ cytotoxic T-cells express
Ptch1 and Gli1 protein (de la Roche et al., 2013).
We then examined Gli expression in T-cells from Gli2A
transgenic mice (which overexpress the activator form of Gli2 in
T-cells). Gli2 and Gli1 were expressed in Gli2A T-cells (Fig. 1A).
The ratio of nuclear to cytoplasmic Gli2 was higher in the Gli2A
transgenic T-cells compared to WT CD4+ T-cells, consistent with
the transgenic expression of a transcriptional activator. Interestingly,
we did not observe an increase in nuclear Gli1 protein in the
Gli2A cells compared to WT, despite the fact that Gli1 transcript
(and also the Ptch1 transcript) is upregulated in the transgenic
cells (Rowbotham et al., 2007; Furmanski et al., 2013). The Gli
transcription factors have distinct tissue-specific functions (Mo
et al., 1997; Matise et al., 1998; Bai et al., 2002), and in many
tissues it has only been possible to identify a function for Gli1
when Gli2 is mutated (Park et al., 2000). Our data show that in
T-cells, increased Gli2A protein does not lead to a corresponding
increase in nuclear Gli1 protein, suggesting that regulatory
feedback mechanisms influence protein levels. This would be
consistent with the fact that Gli1 deficiency makes little functional
impact unless Gli2 is absent.
Given that WTCD4+ cells express Gli2 and Gli1 directly ex vivo,
and that Gli2 localised to the nucleus, we next investigated the
influence of Gli2 transcriptional activity on CD4+ T-cell phenotype
and function.
Fig. 1. CD4+ T-cell phenotype of Gli2A mice. (A) Western blotting with anti-
Gli2 or -Gli1 antibody on cell extracts from purified CD4+ splenocytes of WT
and Gli2A mice. Nuclear control, anti-laminA antibody; cytoplasmic control,
anti-vinculin antibody. (B) Mean±s.e.m. number of CD4+ lymphocytes in
spleen from WT (n=14) and Gli2A (n=15) mice. (C) Histograms showing
representative expression of CD3 and CD69 on CD4+ T-cells from spleen of
WT and Gli2A mice. The percentage of cells that are CD3+ or CD69+ is also
indicated, and the mean fluorescence intensity (MFI) of anti-CD3 staining is
shown in italics (n=7 pairs, percentage CD3+, P<0.03 compared with WT; the
MFI of CD3+ cells and percentage of CD69+ is not significantly different from
WT). (D) Representative CD62L and CD44 expression profiles on splenic
CD4+ cells and (E) percentage (mean±s.e.m.) of CD4+ T-cells from WT (n=5)
and Gli2A (n=5) spleen that are CD62Lhi CD44− (naïve, *P=0.03), CD62L+
CD44+ (central memory, CM) and CD62L− CD44+ (effector memory, EM).
(F) Histograms show CD62L expression on CD4+ T-cells with MFI in italics
(Con, unstained control) from a representative example of n=5 pairs.
P<0.002 for WT compared with Gli2A.
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Phenotype of T-cells expressing Gli2A
We compared the CD4+ cell phenotype of WT mice and Gli2A
transgenic mice. Compared to WT, CD4+ T-cell numbers in Gli2A
spleen were not significantly different to those inWT (Fig. 1B), and
ex vivo, these T-cells expressed similar levels of the TCR-associated
signalling molecule CD3 and low levels of the early activation
marker CD69 (Fig. 1C). Interestingly, compared to WT, a lower
proportion of Gli2A CD4+ cells were CD62L+ CD44− (CD62L is
also known as L-selectin) (Fig. 1D), a phenotype associated with
naïve T-cells. However, there was no equivalent increase in CD44+
cells (effector memory or central memory) in Gli2A spleen
(Fig. 1E), suggesting that Gli2A does not alter the distribution of
T-cells among memory subsets. CD44– cells that are also either
CD62Llo or CD62L– are seen in the Gli2A CD4+ population. Such
cells are not readily detectable in WT spleen. Instead we observed
that the presence of Gli2A in CD4+ T-cells downregulated the level
of surface CD62L (Fig. 1F).
Gli2A negatively regulates T-cell activation and proliferation
We then examined expression of the activation marker CD25 on
CD4+ cells treated with antibody against CD3 and CD28 (hereafter
anti-CD3/CD28) through a 3-day time-course. In response to
stimulation, Gli2A CD4+ cells were less able to upregulate surface
CD25 (Fig. 2A,B) than WT cells at any time point examined,
suggesting that activation of Gli2A T-cells is defective with slower
kinetics throughout the response.
We therefore assessed Gli2A CD4+ cell proliferation following
CD3/CD28 ligation. We cultured WT and Gli2A CFSE-labelled
splenocytes with anti-CD3/CD28 and analysed dye dilution at 72 h.
Consistent with impaired activation, we observed proportionally
fewer CFSElow peaks compared to WT cells (Fig. 2C) and an
increased percentage of undivided CFSEhi CD4+ cells (Fig. 2C,D)
in Gli2A cultures compared to WT. These data complement our
previous findings that T-cell-specific repression of Gli-dependent
transcription increases TCR-driven T-cell activation and
proliferation (Rowbotham et al., 2008).
Gli-dependent transcription alters cell survival
Our data show that Gli-dependent transcription influences T-cell
activation and proliferation (Fig. 2; Rowbotham et al., 2007;
Rowbotham et al., 2008). Population expansion is a dynamic process
and the overall outcomewill depend on the balance between activation,
division and cell death. We therefore investigated apoptosis in Gli2A
activation cultures by assessing cell surface binding of Annexin V
(AnnV), a marker of membrane-flipping during early apoptosis.
A higher percentage of Gli2ACD4+ cells bound AnnV relative toWT
after 24 h in activation cultures, indicating an increased proportion of
cells undergoing the early stages of apoptosis (Fig. 3A). In order to
determine whether this applies only to death of activated T-cells, we
stained control, unstimulated splenocyte cultures at 72 h with AnnV.
Again, Gli2ACD4+ cell populations displayed greater AnnV staining
than WT, indicating increased apoptosis (Fig. 3B). To further
investigate, we measured propidium iodide staining in WT and Gli2A
CD4+ lymphocytes after 24 h in culture with increasing anti-CD3/
CD28 dose (Fig. 3C). Propidium iodide is actively excluded from live
cells; hence, propidium iodide uptake represents membrane
permeability and late-stage apoptosis. As with AnnV, we noted
an increased proportion of cells undergoing apoptosis in unstimulated
and stimulated (0.01 µg/ml) Gli2A cultures compared to WT.
Interestingly, as anti-CD3/CD28 dose increased log-fold we observed
large increases in propidium iodide staining in Gli2A CD4+ cells
indicatingwidespread apoptosis in the cultures,whereas themajority of
WT cells were still able to exclude propidium iodide.
Taken together, these data suggest that Gli-dependent
transcription in T-cells impairs cell survival and increases the
likelihood of cell death.
Gli2 activity impairs IL-2 production by activated T-cells
T-cell activation stimulates the production of IL-2, a potent T-cell
growth and survival factor. As Gli2A cells display attenuated
activation, a proliferation defect and an increased tendency to
undergo apoptosis, we tested the capability of Gli2A cells to
produce IL-2. After a short mitogenic stimulation of splenocytes
directly ex vivo, we found that significantly fewer CD4+ Gli2A cells
expressed intracellular IL-2 compared to WT (Fig. 3D). To confirm
that this effect was cell intrinsic and not due to bystander effects
from other splenocytes, we purified CD4+ T-cells and cultured
them with anti-CD3/CD28-coated beads for 72 h. We found that
compared to WT, a lower proportion of Gli2A cells expressed
intracellular IL-2 at 48 h (Fig. 3E). Strikingly, IL-2hi CD25+ cells,
which are likely to be fully activated and signalling in an autocrine/
paracrine manner, were significantly diminished in Gli2A cultures
compared to WT (Fig. 3E) at both 48 h and 72 h. Gli2A culture
supernatants contained less IL-2 protein than WT cultures as
measured by ELISA at 24 h, 48 h and 72 h. This was most
pronounced and statistically significant at 48 h (Fig. 3F).
Exogenous IL-2 does not rescue the phenotype of Gli2A cells
Activated Gli2A cells produce less IL-2 than WT cells, and show
decreased proliferation and increased apoptosis. To test whether this
Fig. 2. Gli2-mediated transcription attenuates T-cell activation kinetics.
(A,B) Gli2A andWT splenocytes were cultured with 0.01 μg/ml anti-CD3/CD28
for three days. Cells were stained with anti-CD25 and anti-CD4 antibody.
(A) Expression of CD25 on CD4+ cells after 3 days. Histograms show the
percentage of CD25+ cells in WT (solid line) and Gli2A (dotted line). (B) Chart
shows the percentage (mean±s.e.m.) of CD4+ T-cells that express cell-surface
CD25 (n=3 mice per group, *P<0.05). (C) CD4+ cell division measured by
CFSE dilution at 72 h after activation with anti-CD3/CD28. Histogram bar and
label shows the percentage of cells that had not divided. (D) Percentage
(mean±s.e.m.) of CD4+ cells that had not divided after 72 h in WT and Gli2A
activation cultures, n=4, *P=0.04.
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phenotype can be rescued by exogenous IL-2, we performed
proliferation experiments where cells were cultured with anti-CD3/
CD28 in the presence or absence of recombinant-IL-2 (rIL-2).
Addition of rIL-2 did not affect the proportion of dividing cells in
WT or Gli2A cultures after 48 h (Fig. 4A). By 72 h the presence
of rIL-2 had significantly enhanced the proliferation and/or survival
of WT cells (Fig. 4A). However, we observed no significant
enhancement in proliferation of Gli2A cells when exogenous IL-2
was added. We calculated the relative number of cells having
divided more than twice by 72 h, and compared this between
samples cultured with and without exogenous IL-2. In WT cultures,
we found that approximately threefold more cells had undergone
multiple divisions when IL-2 was added together with anti-CD3/
CD28, compared to anti-CD3/CD28 alone. However, this was not
observed in Gli2A cultures (Fig. 4B).
To assess the impact of rIL-2 on maintenance of our cultures, we
assessed cell viability and number. At 72 h, all Gli2A cultures
displayed lower numbers of CD4+ cells compared to WT (Fig. 4C).
The highest cell numbers were observed inWT cultures treated with
anti-CD3/CD28 and rIL-2. However, there was a marked decrease
in CD4+ cell number in the equivalent Gli2A cultures (Fig. 4C).
These data indicate that IL-2 responsiveness is attenuated when
Gli2-dependent transcription is active. Gli2A cells proliferate less
well than WT cells (Fig. 2) and produce less IL-2 upon TCR
stimulation (Fig. 3), and their proliferation defect cannot be rectified
by the addition of exogenous IL-2. In contrast to WT cells, Gli2A
cells do not fully upregulate CD25 upon activation (Fig. 2A,B).
CD25 is an important subunit of the high-affinity receptor for IL-2.
Therefore, because CD25 upregulation is lower on Gli2A than on
WT cells, it seems likely that Gli2A cells express a lower density of
high-affinity IL-2R on the cell surface than WT. IL-2, either added
to or produced by Gli2A cells in culture might therefore be
saturating due to decreased IL-2R availability. Alternatively, Gli2A
cells might have defective intracellular IL-2–IL-2R signalling.
Gli2 activity does not affect the ability of CD4+ cells to
transduce IL-2 signals through STAT5
To determine whether Gli2A cells are less able to transduce
IL-2 signals independently of TCR signalling and subsequent
CD25 upregulation (i.e. in the presence of IL-2 alone, without any
other T-cell stimulation), we cultured fresh splenocytes directly ex
vivo for 15 min with recombinant IL-2 and measured expression of
intracellular phosphorylated signal transduction and activator of
transcription 5 (pSTAT5), a major transcription factor that is
activated downstream of IL-2 signalling (Gilmour et al., 1995). We
found no significant difference in the proportion of cells expressing
pSTAT5 between WT and Gli2A CD4+ cells (Fig. 4D), suggesting
that Gli2A cells do not have an inherent inability to transduce IL-2
Fig. 3. Gli2A-driven transcription enhances apoptosis and
impairs IL-2-responsiveness during division. (A) Percentage
(mean±s.e.m.) of CD4+ AnnV+ (early apoptotic cells) as
determined by live gating from splenocyte activation cultures (24 h,
n=5 experiments, *P=0.02) and (B) percentage of CD4+ AnnV+
cells in unstimulated cultures (72 h, n=3, *P=0.02). (C) Propidium
iodide (PI) staining of CD4+ splenocytes at 24 h after stimulation
with anti-CD3/CD28 (0, 0.01, 0.1 or 1.0 µg/ml; 0, unstimulated).
Histograms are representative of two experiments. Dotted,
background staining; dark-grey, WT; light-grey, Gli2A. (D)
Intracellular IL-2 staining in fresh CD4+ splenocytes following 3 h
activation with PMA (50 ng/ml), ionomycin (500 ng/ml) and
Brefeldin A (2 ng/ml). Bars on shaded histograms show the
percentage of IL-2+ and IL-2hi cells, gated on CD4+ cells; the
dashed grey line shows background staining. A representative
example from five experiments is shown (IL-2hi, WT, 25.0%±0.6,
Gli2A: 19.9±1.5, P=0.009). (E) Purified CD4+ cells were cultured
with anti-CD3/CD28-coated beads for up to 3 days. Surface CD25
and intracellular IL-2 were measured by flow cytometry at the times
indicated, the percentage of CD25+ IL-2+ cells (large gate) and
CD25+ IL-2hi cells (smaller gate, labelled in italic numerals). Gates
were set according to isotype control staining of CD4+ cells (lower
panels). Results are representative of three experiments (n=3, WT
versusGli2Apercentage forCD25+ IL-2+ cells at the48 h time-point,
P<0.01 compared with WT). (F) ELISA showing mean±s.e.m. IL-2
produced by purified CD4+ cells cultured with anti-CD3/CD28-
coated beads (WT, n=5; Gli2A, n=4). *P=0.04.
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signals that result in phosphorylation of STAT5. To assess the
impact of T-cell activation on STAT5 phosphorylation in WT and
Gli2A cells, we measured pSTAT5 levels in CD4+ cells from
activation cultures (Fig. 4E). As expected, unstimulated and anti-
CD3/CD28-stimulated CD4+ cells showed similar pSTAT5
expression in WT and Gli2A cultures. However, we noted a
marked decrease in pSTAT5 expression in Gli2A cells from cultures
stimulated with anti-CD3/CD28 in the presence of IL-2. These
experiments indicate that the inability of Gli2AT-cells to upregulate
CD25 and proliferate efficiently on CD3/CD28 ligation is not
simply the result of reduced IL-2 signalling, but is rather the direct
influence of Gli-mediated transcription on TCR–CD28 driven cell
activation. We, therefore, investigated TCR signalling in this model.
Gli2-driven transcription regulates the T-cell Ca2+ flux
Upon TCR ligation, T-cells undergo a sustained influx of Ca2+ ions
across the plasmamembrane,which stimulates the release ofCa2+ from
intracellular stores, triggering signalling pathways and the activation
of transcription factors including NFκB and NFAT. Impaired Ca2+
flux has been shown to diminish events downstream of TCR activation
necessary for proliferation and survival, including IL-2 production
(Feske, 2007). In order to determine whether Gli-dependent
transcription influences the Ca2+ flux, we activated Gli2A T-cells
and monitored Ca2+ entry into cells loaded with Fluo-4-AM, a
Ca2+-binding fluorescent dye. Baseline fluorescencewasmeasured for
60 s prior to TCR stimulation. We observed a sustained Ca2+ flux in
WT T-cells following cross-linking of surface CD3 molecules
(Fig. 5A, upper panels). In comparison, Gli2A cells showed a
diminished flux of lower magnitude (Fig. 5A–C). Gli2A cells were
able to undergo a Ca2+ flux that was comparable to WT cells upon
stimulationwith ionomycin, a Ca2+ ionophore (Fig. 5A, lower panels),
indicating that the impaired fluxes seen with anti-CD3 activation were
due to defective TCR signalling.
NFAT transcription factors are crucial regulators of T-cell
function during activation. TCR-induced Ca2+ flux triggers
dephosphorylation and translocation of NFAT proteins to the
nucleus, where they modulate T-cell transcription. In order to assess
whether the impaired Ca2+ flux in Gli2A cells affected nuclear
expression of NFAT, we performed western blotting for NFAT2 on
nuclear extracts of WT and Gli2A CD4+ cells following anti-CD3/
CD28 stimulation (Fig. 5D). As expected given their weak Ca2+
flux, Gli2A cells showed lower expression of nuclear NFAT2 after
stimulation.
Our data show that Gli2, a transcription factor that is expressed in
WTcells,modulates T-cell biology throughmechanisms downstream
of the TCR. We therefore sought to examine the transcriptional
mechanisms involved in the influence of Gli-dependent transcription
on TCR signalling during the early stages of T-cell activation.
Expression of Gli proteins in Gli2R CD4+ T-cells
We have shown that Gli2A cells highly express Gli2 protein in
T-cell nuclear extracts (Fig. 1A). These cells also constitutively
express high levels of Ptch1 transcript, a Hh-target gene (Furmanski
et al., 2013). Additionally, we have shown that Gli2R transgenic
Fig. 4. Gli2-dependent transcription decreases IL-2 production
and CD25 (IL2R) upregulation. (A) Histograms representing dye
dilution measured by flow cytometry over time in CFSE-loaded
CD4+ splenocytes activated with 0.01 μg/ml anti-CD3/CD28
without (stim, black line) or with 10 U/ml rIL-2 (stim+IL-2, shaded).
Histograms show overlays of stimulated and stimulated +IL-2
cultures, bar markers show the peak representing the undivided
population. (B) Flow Jo software was used to calculate cell
proliferation in cultures. The number of cells in each generation
(peak) was estimated and the relative effect of IL-2 on cultures was
calculated. The bar chart shows number of cells undergoing more
than three divisions in stim+IL-2 cultures relative to stim alone
(mean±s.e.m. n=4 pairs, *P=0.001). (C) Number of live CD4+ cells
remaining in culture at 72 h (n=3, *P<0.03) and (D) phospho-
STAT5 staining in CD4+ splenocytes that were unstimulated (left
panels) or following 15 min culture with 10 ng/ml IL-2 (right panels;
WT n=3, 8.9±1.5%; Gli2A n=4, 8.4±1.6%, which is not significantly
different from WT). (E) Phospho-STAT5 staining in CD4+
splenocytes cultured for 48 h with IL-2 or anti-CD3/CD28+IL-2.
Histograms showing the percentage of phospho-STAT5+ cells,
representative of two independent experiments. WT, dark-grey;
Gli2A, light grey.
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CD4+ cells are refractory to upregulation of Ptch1 on Shh treatment
(Rowbotham et al., 2008), and therefore that physiological Hh
signalling is inhibited in these cells. In contrast to Gli2A cells,
T-cells from Gli2R transgenic mice show an enhanced activation
phenotype compared to WT controls, and displayed increased
proliferation after 72 h in culture with anti-CD3/CD28 (Rowbotham
et al., 2008). Gli2A and Gli2R proteins are isoforms of the same
transcription factor but might reside in different cellular locations
due to their distinct functions. We therefore investigated Gli2
protein expression in Gli2R CD4+ cells by western blotting of cell
extracts. As expected, Gli2R cells expressed Gli2 (Fig. 6A).
Interestingly, there was a lower nuclear to cytoplasmic ratio of Gli2
compared to WT cells, and Gli2R cells also displayed lower
abundance of Gli1 protein, itself a canonical Gli-target (Fig. 6A),
reflecting the repressor function of the transcription factor.
Regulation of CD4+ T-cell transcription by Gli2
We have shown that Gli proteins are expressed in WT T-cells, and
that the Gli2A and Gli2R transgenes modulate T-cell transcription
and function. We therefore investigated which genes are regulated
by Gli2 in lymphocytes during TCR stimulation. We measured
Gli2-dependent transcription in fresh and anti-CD3/CD28-activated
CD4+ T-cells from spleen of WT, Gli2A and Gli2R mice by
microarray (GSE33156, GEO depository) as described previously
(Furmanski et al., 2013). We analysed the resting and TCR-
stimulated T-cell data sets separately in order to identify genes
regulated by Gli2 in both the absence and presence of a TCR signal.
Gene lists were obtained from normalised fold-change analyses or
by moderated t-statistics (eBayes Limma analysis) with false
discovery rate and adjusted P<0.05.
Identification of newGli target genes in unstimulated T-cells
Both transgenic strains carry a transgene encoding Gli2 and share
consensus DNA-binding sequences in target genes. We aimed to
identify potential direct Gli target genes in CD4+ T-cells directly
ex vivo. We therefore filtered gene lists by screening genes with
an expression pattern across genotypes correlating to Ptch1,
a canonical Gli target gene in T-cells (Furmanski et al., 2013), to
identify 33 genes upregulated in Gli2A and downregulated in Gli2R
unstimulated T-cells (supplementary material Table S1). We used
the DAVID v6.7 bioinformatics resource (Huang et al., 2009) to
cluster these genes into seven functional groupings according to
gene annotations. Over a third of these genes encoded membrane-
bound proteins and receptors, several of which are involved in the
regulation of growth, differentiation or cell death (Igf1r, Ifitm3, C6,
Mmp13, Ptlp and Qk) and transport (Slc1a3, Slc25a39, Slc16a9).
Others functional groupings included signal transduction, catabolic
processes, proteolysis and ion or nucleotide binding. Several genes
positively regulated by Gli2A have been implicated in T-cell
function: Rsad2 (also known as viperin) is an anti-viral protein and
facilitator of Th2 cytokine production. Ifitm3, Hfe and Tnfsf12 (also
known as TWEAK) were also positively regulated by Gli-dependent
transcription.
We identified six genes downregulated in Gli2A and upregulated
in Gli2R unstimulated CD4+ cells (supplementary material
Table S1). Hspa1a and Hspa1b are anti-apoptotic and involved in
NFκB activation. Interestingly, Igfbp4 and Sostdc1 both act as BMP
or Wnt pathway inhibitors, demonstrating the complex relationship
between these major morphogenic pathways. These genes are
unlikely to be direct targets of Gli2, as expression decreases when
the transcriptional activator form of Gli2 is present, but might be
targets of currently unidentified intermediate repressor genes, which
are themselves targets of Gli2.
Gli-mediated transcription in resting and activated T-cells
controls expression of morphogenic, developmental and
immune cell signalling genes
Array data were further analysed using a cut-off of a 1.5-fold
difference in gene expression between genotypes, for unstimulated
and stimulated datasets (supplementary material Fig. S1). This
showed that several hundred genes were regulated by Gli2. Anti-
CD3/CD28 stimulation reduced the number of transcripts that were
differentially expressed between genotypes, most likely due to the
potent effect of TCR signalling on the T-cell transcriptome. The
Gli2A and Gli2R transgenes might not control expression of an
identical set of genes in a reciprocal manner, as the cellular location,
transcription-complex-binding partners, stability and secondary
indirect effects of the Gli2A and Gli2R transcription factor isoforms
Fig. 5. Gli-mediated transcription regulates the T-cell Ca2+ flux.
(A) Splenocytes were loaded with Fluo-4-AM (3 µM) and surface stained. Cells
were incubated with hamster anti-mouse-CD3 antibody (3 µg per 106 cells) for
20 min on ice, washed, resuspended in PBS containing Ca2+ and incubated at
37°C prior to acquisition by flow cytometry. Cells were stimulated with 9 µg
cross-linking anti-hamster-IgG antibody or 0.1 µg/ml ionomycin. Fluorescence
intensity in FL-1 (Fluo-4-AM) was recorded during the 60 s baseline and for a
further 4 min through the peak of flux (B, n=5, *P=0.03). The relative change
in MFI [100×(peak−baseline)/baseline] was calculated (percentage flux) for
(C) WT and Gli2A (mean±s.e.m., *P=0.02). (D) Western blotting of NFAT2 in
nuclear extracts from purified CD4+ cells, which were activated for 24 hwith 2.5
µg/ml plate-bound anti-CD3/CD28. Loading control, anti-laminA antibody.
2090
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 2085-2095 doi:10.1242/jcs.165803
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
might differ. To widen our analysis, we identified genes that were
differentially expressed in either transgenic strain compared to
all other samples. Unstimulated Gli2A T-cells showed upregulation
of genes encoding important signalling molecules, including
Tgfb3, Sox4, Dusp16 and Hoxa1. Members of related morphogen
signalling pathways, including Bmpr2 and Wnt5b, were also
upregulated when Gli2-mediated transcription was active. Gli2A
expression in T-cells caused downregulation of genes encoding
heat-shock proteins (Hsp90aa1, Hspa1a and Hspa1b), and most
interestingly, molecules important in T-cell signalling including
Jun, Fos, Fosb, Lef1, Ikbkb and Rasgrp1 (supplementary material
Fig. S1, selected genes annotated only for clarity). Sell, encoding
CD62L was also downregulated in Gli2A cells. This reflects our
observations that Gli2A T-cells express lower levels of cell-surface
CD62L (Fig. 1D,F) and suggests that the CD62L and CD44
phenotype of Gli2A CD4+ cells is influenced by Gli2 at a
transcriptional level, rather than by shedding of CD62L protein
(Kahn et al., 1994; Hafezi-Moghadam et al., 2001). These genes are
all likely to be targets of intermediate repressor genes, which are
themselves targets of Gli2. The expression of Gli2R in T-cells
caused downregulation of morphogenic genes including Sox6,
Fzd7, Hoxd1 and Nkx1.2. Other genes repressed by Gli2R included
several with important roles in the regulation of immune cell
signalling (Il1b, Cd24a, Vsig4 and Bcl11a).
When T-cells were stimulated with anti-CD3/CD28 for 6 h, we
observed that several genes upregulated in the Gli2A or
downregulated in the Gli2R groups encoded molecules involved
in immune cell signalling and apoptosis, including Csf2, Cd24a,
Fasl and Jdp2. As in unstimulated Gli2A cells, regulators of
morphogenesis, growth and/or differentiation (Igf1r, Tgfb3, Hoxa1,
Bmpr1b and Sox4) were upregulated in stimulated Gli2A cells, and
Igfbp4 and Jun were downregulated. Interestingly, Il6, Tgfbi and
Il17a were repressed by the presence of Gli2R (supplementary
material Fig. S1, selected genes only are labelled for clarity),
suggesting that Gli2-dependent transcription might play a role in
Th17 cell differentiation.
Il2ra and Il2 expression was similar in stimulated Gli2A and WT
cells, confirming that the influence of Gli2A on activation-induced
upregulation of cell surface CD25 and intracellular IL-2 protein
(Figs 2–4) is not a direct transcriptional consequence of the
transgene, but rather the consequence of the overall reduction in
T-cell activation. This indicates that the failure of Gli2A cells to
fully upregulate CD25 and synthesise IL-2 (Figs 2–4) is not an
artefact due to constitutive overexpression of Gli2, as expression of
these genes is not decreased by the presence of Gli2A in T-cells.
We confirmed relative gene expression by quantitative real-time
PCR (qPCR) using RNA left over from array experiments (not
shown) and from additional samples in independent experiments
to validate our microarray results. Tgfb3, a gene identified in
the microarray experiment as upregulated in Gli2A cells and
downregulated in Gli2R cells compared to WT was found to follow
this expression pattern in additional samples (supplementary
material Fig. S2A). This transcript encodes TGFβ3, a TGFβ
family member, expressed by CD4+ T-cells and important in Th17
cell pathogenesis (Lee et al., 2012). There is cross-talk between
TGFβ and Shh–Gli signalling pathways; TGFβ can activate GLI2
Fig. 6. Gli2A-driven transcription attenuates expression and
DNA-binding activity of key T-cell transcription factors.
(A)Western blotting as in Fig. 1A on extracts from purified CD4+ cells
from WT and Gli2R mice. (B) AP-1 activity (arrow) was assessed by
EMSA in lymphocytes from WT (n=3), Gli2R (n=3) and Gli2A (n=3)
mice activated with 1.25, 2.5 and 5 µg/ml plate-bound anti-CD3/
CD28. (C) Supershift assays were performed with anti-Fos and anti-
Jun antibodies following EMSA. (D) Protein expression of the IKKβ
subunit was assessed by western blotting of CD4+ cell lysates from
WT (n=3), Gli2R (n=3) and Gli2A (n=3), anti-actin blotting was
performed as the loading control. (E) NFκB activity was probed by
EMSA as described above, where cells were activated with 2.5 µg/ml
or 5 µg/ml anti-CD3/CD28 as indicated.
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expression in several cell types (Dennler et al., 2007), and GLI2
directly binds and activates transcription of the TGFB1 gene in
human CD4+ T-cells (Furler and Uittenbogaart, 2012). Our data
strongly suggest that Tgfb3, among other TGF-related genes, is
a direct transcriptional target of Gli2 in murine CD4+ cells,
uncovering further overlap of these pathways.
Rasgrp1 showed the opposite expression pattern; it was
downregulated in Gli2A and upregulated in Gli2R cells. This
indicates that its expression is negatively regulated by Gli2-mediated
transcription (supplementary material Fig. S2B), most likely through
an intermediate repressor gene. Other potential Gli-target genes
(supplementary material Fig. S2C; Igf1r, Hoxa1, Ifitm3) or targets of
intermediate repressors (supplementary material Fig. S2D; Igfbp4,
Ikbkb, Hspa1a, Nfkbiz) were also confirmed by qPCR.
Major components of the TCR signalling pathway are
differentially expressed when Gli2 is active or repressed
Rasgrp1 encodes an important nucleotide exchange factor that
specifically activates Ras, a major upstream component of the
ERK (MAPK) pathway. Rasgrp1 controls T-cell development,
differentiation and activation (Reynolds et al., 2004; Priatel
et al., 2006; Priatel et al., 2010). We have previously shown
defective ERK activation in Gli2A T-cells (Rowbotham et al.,
2007). Decreased expression of Rasgrp1 (supplementary material
Fig. S2B) could be one mechanism by which Gli2A negatively
regulates T-cell activation. Downstream of the TCR, Ras–ERK–
MAPK signalling culminates in the activation of key T-cell
transcription factors including AP-1. We therefore examined the
activity of AP-1 by performing an electrophoretic mobility shift
assay (EMSA) following activation of lymphocytes with anti-CD3/
CD28. Interestingly, we found decreased binding of AP-1 probes to
Gli2A lymphocyte nuclear extracts compared to WT, indicating
impaired DNA-binding activity of AP-1 in T-cells from these mice
(Fig. 6B). AP-1 is made up of complexes of Fos and Jun proteins.
We therefore performed gel supershift assays to assess the
composition of bound AP-1 in WT, Gli2A and Gli2R cells by
blotting with antibodies against cFos, Fos B, Jun B and Jun D. In all
cases, Gli2A cells showed decreased expression of these proteins
on TCR–CD28 ligation (Fig. 6C), consistent with the overall
reduction of AP-1 activation (Fig. 6B). In contrast, although
overall Gli2R transgenic cells showed somewhat decreased AP-1
activity compared to WT (Fig. 6B), the specific contribution of
FosB and JunB to AP-1 was increased. Thus, Gli2 activity regulates
the expression of these major transcription factors in T-cells.
Ikbkb encodes IKKβ, a protein forming part of the IκB kinase
(IKK) complex, which phosphorylates inhibitors of NFκB,
allowing translocation of the active NFκB transcriptional complex
to the nucleus. Expression of Ikbkb transcript was negatively
regulated by Gli2-mediated transcription (supplementary material
Fig. S2D). We used western blotting to examine expression of IKKβ
protein in WT, Gli2A and Gli2R CD4+ cell lysates. There was
increased expression of IKKβ in Gli2R samples, whereas Gli2A
showed lower levels than the WT sample (Fig. 6D). We therefore
examined activity of NFκB in nuclear extracts by EMSA. Binding
was severely diminished in the Gli2A sample compared to WT,
whereas Gli2R extracts showed enhanced binding compared to WT,
particularly at the lower concentration of stimulating anti-CD3/
CD28 antibody (Fig. 6E).
We therefore show that Gli2A activity in T-cells impaired full
T-cell activation by at least three different mechanisms: (1)
diminished Ca2+ flux and decreased nuclear NFAT2, (2)
decreased AP-1 activation and (3) impaired activation of NFκB.
DISCUSSION
Here, we showed that Gli2A-mediated transcription in T-cells
attenuated T-cell signalling and T-cell activation on CD3/CD28
ligation. We investigated the mechanism of this effect, and showed
that increased Gli2 activation caused a reduction in AP-1 activation
and NFκB activation downstream of TCR signalling. In contrast,
inhibition of physiological Gli2-mediated transcription, in Gli2R
transgenic cells, led to an increase inNFκBactivation, and a change in
the molecular composition of AP-1. Impairment of the activity of
important signalling pathways such as Ras–ERK–AP-1 and IKK–
NFκB byGli2Awould influence T-cell biology, potentially affecting
immune cell differentiation and adaptive immunity. Subsequent
dysregulation of IL-2 receptor upregulation, signalling and/or
secretion upon weakened TCR stimulation is likely to further limit
T-cell responses, providing one explanation for the enhanced
apoptosis and decreased numberofGli2AT-cells surviving in culture.
Gli2A cells display normal basal levels of intracellular Ca2+;
however, they lack the ability to undergo a full flux compared to
WT cells upon TCR stimulation, and show decreased nuclear
NFAT2 (Fig. 5). This might point to defective intracellular Ca2+
stores or ion channel pumps and is something that requires further
investigation. The alteration of AP-1 and NFκB activity and
impairment of Ca2+ fluxing by Gli-dependent transcription are
important findings, contributing to our understanding of how Hh
and/or Gli signals act to ‘tune down’ TCR signalling, as observed
previously during T-cell development and activation (Outram
et al., 2000; Rowbotham et al., 2007; Rowbotham et al., 2008;
Rowbotham et al., 2009; Drakopoulou et al., 2010; Furmanski
et al., 2012).
We have previously reported that Gli2A transcriptional activity in
T-cells directly increases the production of IL-4 and subsequent
expression of Gata3, promoting differentiation to the Th2 lineage
(Furmanski et al., 2013). It is interesting to note that differentiation of
naïve CD4+ T-cells to Th2 cells is associated with lower TCR signal
strength. TCR signals triggered by low cognate peptide concentration
stimulateweak and transient ERKactivation, allowingGata3 and IL-4
expression, which favours Th2 differentiation (Yamane et al., 2005).
Therefore, another mechanism for Gli2A to promote Th2
differentiation is by decreasing the strength of the TCR signal by
attenuating ERK activation.
Microarray profiling revealed additional wide-ranging effects of
Gli2-driven transcription on T-cell gene expression, including
positive regulation of several genes involved in T-cell function.
These include Tgfb3, which is important in Th17-mediated
autoimmunity (Lee et al., 2012), Igf1r, which is highly expressed
in T-ALL cells (Medyouf et al., 2011), Rsad2 (viperin), which is
a regulator of viral infection (Seo et al., 2011), Cd24a, which
is important in T-cell homeostasis (Li et al., 2004) and Dusp16,
which is a negative regulator of JNK in T-cells (Kumabe et al.,
2010). It therefore seems likely that Hh and/or Gli signalling has
uncharacterised roles in the modulation of autoimmunity and
response to infection.
Hh- and Gli-related molecules or genes involved in development
and oncogenesis in other tissues were also found to be differentially
regulated in Gli2A and Gli2R T-cells including Ptch1, Bmpr2,
Wnt5b, Hoxa1 and Sox4. Our data and others (Lowrey et al., 2002)
indicate a role for Hh–Gli signalling in modulating cell division
and apoptosis. It is therefore timely and important to examine the
role of Hh signalling and/or Gli-mediated transcription in T-cell
malignancies, particularly as subtypes of lymphocytic leukaemia
have been shown to have differing Hh dependency (Decker et al.,
2012).
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The role of Hh signalling in influencing the outcome of
peripheral T-cell activation in both human and mouse is
controversial. In some studies, addition of recombinant Shh to T-
cell cultures activated with sub-optimal concentrations of anti-CD3/
CD28 led to increased activation and proliferation, whereas anti-Hh
antibody reduced cell proliferation (Lowrey et al., 2002; Chan et al.,
2006). However, conditional deletion of Smo or Ptch1 had no
significant effect on T-cell proliferation kinetics when anti-CD3
stimulating antibodies were used in vitro (El Andaloussi et al., 2006;
Michel et al., 2013). Our data shows that Gli2-mediated
transcription attenuates T-cell activation and proliferation. Our
current and previous studies (Rowbotham et al., 2007; Rowbotham
et al., 2008) largely use a T-cell-specific transgenic approach, in
order to rule out cell-extrinsic secondary mechanisms and non-
specific effects from high concentrations of recombinant protein,
such as those from suspected endotoxin contamination of
commercially available recombinant Shh (Wakelin et al., 2008).
Additionally, there is emerging evidence in some cell types for non-
canonical Hh–Gli signalling, such as Smo-independent signalling,
Hh-dependent Smo-dependent Gli-independent signalling, or Hh-
independent activation of Gli transcription (Hui and Angers, 2011;
Brennan et al., 2012). Our Gli2A and Gli2R transgenic systems are
designed to investigate the specific influence of Gli-mediated
transcription on T-cell gene expression and function. This will
reflect Hh-dependent transcription, as Gli-mediated transcriptional
activation is downstream of canonical Hh signalling. Indeed, we
have previously shown that canonical Hh target genes are up- and
down-regulated in Gli2A and Gli2R cells respectively, and that in
T-cells, Smo mimics this expression pattern (Furmanski et al.,
2013). However, as T-cells lack cilia (Finetti et al., 2011), there are
likely to be differences in Hh signal transduction in T-cells
compared to ciliated cells. In ciliated cells, upon ligand binding to
Ptch1, the signal transduction molecule Smo is trafficked along the
primary cilium, and movement of Smo is believed to be essential for
signalling (Rohatgi et al., 2007). In the case of T-cells, the absence
of cilia could explain apparent inconsistencies between conditional
Smo−/− (El Andaloussi et al., 2006), conditional Ptch1−/− (Michel
et al., 2013) and Gli2A or Gli2R transgenic models. Furthermore,
the potential for activation of Gli proteins by non-Hh signalling
pathways, such as through TGFβ signalling, could explain
discrepancies in observations made in Gli2A and Gli2R systems
and those using recombinant Hh protein in cell culture. These
questions require further investigation.
The specific activity ofmorphogens like Hh family proteins varies
with cellular context. The complex role for Hh–Gli signalling in
T-cell activation requires further dissection, and might have wide-
ranging effects on the immune response in health and disease.
Increased expression of Hh protein or other molecules that
can trigger Gli activity during tissue renewal could attenuate local
T-cell responses, potentially aiding repair or skewing local immune
responses. We have previously shown that Hh proteins are
upregulated in the lung following the induction of allergic lung
disease (Furmanski et al., 2013), and Shh is known to be upregulated
in chronic pulmonary fibrosis (Stewart et al., 2003), in inflammatory
gut disease (Nielsen et al., 2004), in wound healing (Le et al., 2008)
and after tissue ischemia (Pola et al., 2003). Importantly, many
cancers overexpress Hh ligands (Jiang and Hui, 2008). In addition to
its oncogenic functions, our work suggests that Hh might also signal
to local T-cells to decrease activation. Hh-driven suppression of a
local T-cell immune response could uncover a previously unknown
but targetable role for Hh signalling and/or Gli-dependent
transcription in anti-tumour immunity.
MATERIALS AND METHODS
Mice
Lck-Gli2ΔN2 (Gli2A) (Rowbotham et al., 2007) and Lck-Gli2ΔC2 (Gli2R)
(Rowbotham et al., 2008) C57BL/6-background transgenic mice were as
described. All experiments were performed with littermate age-matched
control mice under the ethical authority of the United Kingdom Home
Office and local regulations.
Cell culture
To activate T-cells, splenic cells at 5×106 per ml were cultured in AIMV
medium (Invitrogen) with 10−5 M β-mercaptoethanol (Sigma-Aldrich, UK)
with or without soluble anti-CD3 and anti-CD28 (BD Pharmingen, UK, 0.01
μg/ml unless otherwise stated) or anti-CD3/CD28-coated beads (1:1 bead:cell
ratio, Invitrogen Life Tech, UK), andwith orwithout recombinantmouse IL-2
(Roche, UK, 10 U/ml) or Shh (R&D Systems, UK, 300 ng/ml). Magnetic
bead separation was performed using EasySep CD4+ cell negative selection
(StemCell Tech, France) according to the manufacturer’s instructions.
Flow cytometry, ELISA and antibodies
Cells were stained and analysed as described previously (Furmanski et al.,
2013) on a BD C6 Accuri flow cytometer. CFSE labelling (10 µM in PBS)
was performed as described (Rowbotham et al., 2007). Intracellular-
cytokine and AnnV staining was performed using eBiosciences UK Fix/
Perm and permeabilisation buffers and AnnV-binding buffers, respectively.
Propidium iodide staining was performed in PBS immediately after cell
surface staining, using 0.5–1.0 µg/ml propidium iodide (Sigma).
Intracellular phospho-protein staining was performed using commercial
buffers, BD Lyse/Fix and permeabilisation buffer III (BD Bioscience, UK),
according to the manufacturer’s instructions. ELISAs were performed using
eBioscience Ready-Set-Go mouse IL-2 kits (Affymetrix, UK). Data
represent at least three experiments.
Ca2+ flux
Splenocytes (1×106–2×106) were loaded with 3 µM Fluo-4-AM (Life Tech,
UK) in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Life Tech,
UK) for 30 min at 37°C, washed twice, surface-stained and washed. Cells
for TCR stimulation were additionally surface stained with hamster anti-
CD3 (3 µg per 106 cells, BD, UK) and washed. All cells were resuspended in
PBS containing Ca2+ and Mg2+ (Gibco, Life Tech, UK) and incubated at
37°C until acquisition. Data were acquired on a BD C6Accuri flow
cytometer for 60 s prior to addition of stimuli (<9 µg anti-hamster IgG,
Vector Labs UK; or 100 ng/ml Ionomycin, Sigma, UK).
Microarray and data analysis
Array experiments were performed as described (Furmanski et al., 2013).
Briefly, total RNA was extracted from purified fresh (unstimulated) or 6-h
activated (stimulated) CD4+ spleen cells of WT (n=3), Gli2A (n=3) and
Gli2R (n=3) and was submitted to UCL Genomics for processing and
quality control prior to hybridisation to Affymetrix MOE430 2.0 mouse
whole-genome array chips and data acquisition according to standard
Affymetrix protocols. All microarray data are publicly available (dataset:
GSE33156, GEO depository).
qPCR
qPCR was carried out in triplicate as described previously (Furmanski et al.,
2013). Pre-validated transcript-specific oligonucleotides (Quantitect Primer
Assays, Qiagen, UK) were used except for Hoxa1F (5′-CAGGGAAAG-
TTGGAGAGTACG-3′) and Hoxa1R (5′-TCTGCTTCATGCGGCGA-
TTCTG-3′). Data were normalised to expression of Hprt and represent at
least two independent experiments.
Western blotting
CD4+ cells from spleen (n=3 mice) were purified as described above and
pooled for each group. Protein expression was analysed in nuclear or cell
lysates by western blotting with appropriate antibody [against Gli1 (H-300),
Gli2 (H-300) and IKKβ (H-470) (all Santa Cruz, UK); NFAT2 (D15F1, Cell
Signaling Technology, UK) or control (anti-vinculin, Cell Signaling
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Technology; lamin A, Millipore; or actin, Santa Cruz Biotechnology)] as
previously described (Bellavia et al., 2000; D’Acquisto et al., 2007). Briefly,
cells were lysed in ice-cold lysis buffer (1%NP-40, 20mMTris-HCl pH 7.5,
150mMNaCl, 1 mMMgCl2, 1 mMEGTA, 0.5 mMPMSF, 1 μMaprotinin,
1 μM leupeptin, 1 μM pepstatin, 50 mM NaF, 10 mM Na4P2O7, 1 mM
NaVO4 and 1 mM β-glycerophosphate). Cell lysates were centrifuged at
18,000 g for 5 min at 4°C and the supernatants collected and subjected to
electrophoresis on SDS 10% polyacrylamide gel. Membranes were
incubated overnight with antibodies diluted in Tris-buffered saline
solution containing Tween-20 with 5% non-fat dry milk at 4°C. In all
cases, prior to western blotting, protein concentration in cell extracts was
quantified using a colorimetric Protein Assay kit with reference to a BSA
standard curve (Biorad, UK), according to the manufacturer’s instructions.
This information was used to load equivalent amounts of protein onto gels,
which was confirmed using loading controls.
EMSA and supershift experiments
LN cells of three mice per group and nuclear extracts probed by electro-
mobility shift assays to analyse DNA binding of AP-1 or NFκB, as previously
described (D’Acquisto et al., 2007). Briefly, nuclear extracts (3–5 μg) were
incubated with 2 μg of poly (dI:dC) in 20 μl of binding buffer with 32P end-
labelled, double-stranded oligonucleotide probes (5×105 cpm), and
fractionated on a 6% polyacrylamide gel (29:1 cross-linking ratio) in 0.5%
TBE for 2.5 h at 150 volts. Double–stranded oligonucleotide probes were
from Promega, UK. Supershift EMSAwere performed as above, additionally
using the following antibodies: anti-cFos, -FosB, -JunB, -JunD (all Cell
Signaling Technology)
Data analysis
Statistical analyses were performed usingMicrosoft Excel or Prism 4 (Graph
Pad). Two-tailed unpaired Student’s t-tests were used to assess statistical
significance to P<0.05.
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Figure S1: Gli2-mediated transcription modulates T-cell gene expression
CD4+ splenocytes were obtained directly ex vivo (unstimulated) or from cultures activated
with 0.01μg/ml anti-CD3/CD28 for 6h (stimulated).  Whole-genome microarray analysis 6 
was performed using Affymetrix MOE430 chips and data were analysed to compare fold
change in gene expression. Transcripts in grey are significantly differentially expressed
between the comparison within each scatter plot, selected genes only are labelled for
clarity. Scale is FC [log2], equivalent to a 1.5-fold change.
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Figure S2: qPCR confirmation of Gli-target genes in T-cells
 
 
Gene expression levels in CD4+ T-cells were quantified in triplicate by qPCR relative to
expression of Hprt (Gene/Hprt, arbitrary units), charts show a representative example of
two or three independent experiments. Expression of (A) Tgfb3, (B) Rasgrp1, (C) Igf1r,
Hoxa1, Ifitm3, (D) Nfkbiz, Hspa1b, Igfbp4 and Ikbkb.
Figure S2: qPCR confirmation of Gli-target genes in T-cells
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Table S1: Potential target genes of Gli2 in T-cells.  Genes differentially expressed in 
unstimulated CD4+ T-cell populations of Gli2A vs. WT vs. Gli2R (n=3 per group).  Gene lists 
were obtained by filtering genes that were expressed 1.5x that of WT and that had an expression 
profile similar (r>0.95) to significant DEG or known Gli target genes (eg Ptch1) in reciprocal 
transgenic cells compared to WT.  FC: fold change in expression relative to WT group. 
 
Gene  
symbol 
Gene name FC in  
Gli2A 
FC in  
Gli2R 
Genes upregulated in Gli2A and downregulated in Gli2R vs. WT 
Rsad2 radical S-adenosyl methionine domain containing 2 4.0 -2.9 
Bpgm 2,3-bisphosphoglycerate mutase 3.6 -1.8 
Mmp13 Matrix metallopeptidase 13 2.9 -1.8 
Fam213a family with sequence similarity 213, member A 
(PAMM) 
2.7 -1.5 
Sulf2 sulfatase 2 2.7 -1.6 
Pltp Phospholipid transfer protein 2.5 -2.3 
Ube2l6 ubiquitin-conjugating enzyme E2L 6 2.4 -2.8 
Slc1a3 solute carrier family 1, member 3 (GLAST) 2.1 -1.8 
D030029J20Rik RIKEN cDNA 2.0 -3.8 
C6 complement component 6 2.0 -2.7 
Hfe hemochromatosis 1.9 -1.5 
Kcnc1 potassium voltage gated channel, Shaw-related 
subfamily, member 1 
1.9 -1.8 
Ifitm3 interferon induced transmembrane protein 3 1.8 -1.7 
Chchd7 coiled-coil-helix-coiled-coil-helix domain containing 7 1.8 -3.4 
Mrc1 mannose receptor, C type 1 1.8 -1.6 
Acer1 alkaline ceramidase 1 1.7 -1.7 
Ube2e3 ubiquitin-conjugating enzyme E2E 3 1.7 -1.7 
Usp15 ubiquitin specific peptidase 15 1.7 -3.7 
Rab3il1 RAB3A interacting protein (rabin3)-like 1 1.7 -1.7 
Abcg3 ATP-binding cassette, sub-family G (WHITE), member 
3 
1.7 -1.9 
Timd4 T cell immunoglobulin and mucin domain containing 4 1.7 -1.7 
Themis2 thymocyte selection associated family member 2 1.7 -1.6 
Csf2rb1(Il5rb) colony stimulating factor 2 receptor, beta, low-affinity 1.7 -1.7 
Igf1r Insulin-like growth factor I receptor  1.7 -1.5 
Tnfsf12 tumor necrosis factor (ligand) superfamily, member 12 
(TWEAK) 
1.6 -1.6 
Slc25a39 solute carrier family 25, member 39 1.6 -1.5 
Emr1 EGF-like module containing, mucin-like, hormone 
receptor-like sequence 1 
1.6 -1.6 
Slc16a9 solute carrier family 16, member 9 1.6 -1.5 
Mbtd1 mbt domain containing 1 1.6 -2.5 
Frmd4a FERM domain containing 4A 1.6 -1.9 
Qk quaking 1.6 -1.8 
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Gas2l3 growth arrest-specific 2 like 3 1.5 -1.7 
C2 complement component 2 (within H-2S) 1.5 -1.6 
Genes downregulated in Gli2A and upregulated in Gli2R vs. WT 
Hspa1b Heat shock protein 1B -22.9 1.9 
Hspa1a Heat shock protein 1A -7.3 1.9 
Sostdc1 Sclerostin domain containing 1 -6.8 3.8 
Igfbp4 insulin-like growth factor binding protein 4 -3.4 1.6 
Tmem181 Transmembrane protein 181 -2.6 1.5 
Serpini1 serine peptidase inhibitor, clade I, member 1 -1.6 1.8 
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